Annual report pursuant to Section 13 and 15(d)

Supplemental Information to Consolidated Statements of Cash Flows (Detail)

v3.6.0.2
Supplemental Information to Consolidated Statements of Cash Flows (Detail) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Schedule of Cash Flow, Supplemental [Line Items]      
Cash paid for interest $ 108,101 $ 105,155 $ 107,926
Cash paid for income taxes, net of refunds received 93,368 108,435 122,972
Noncash investing and financing activities:      
Change in accounts payable and accrued expenses for the acquisition of theatre properties and equipment [1] (29,471) 2,491 (1,225)
Theatre properties and equipment acquired under capital lease 33,282 36,544 19,908
Investment in NCM - receipt of common units (see Note 5) 11,111 15,421 8,216
Dividends accrued on unvested restricted stock unit awards (554) (593) $ (530)
Receipt of promissory note related to sale of investment in a Taiwan joint venture $ 2,634    
Other Affiliates | Taiwan Joint Venture      
Noncash investing and financing activities:      
Receipt of promissory note related to sale of investment in a Taiwan joint venture   $ 2,304  
[1] Additions to theatre properties and equipment included in accounts payable as of December 31, 2015 and 2016 were $11,154 and $40,625, respectively.